• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝酮生成不足会重新编程肝糖原代谢和脂质组。

Hepatic ketogenic insufficiency reprograms hepatic glycogen metabolism and the lipidome.

机构信息

Division of Molecular Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.

Center for Metabolic Origins of Disease, Sanford Burnham Prebys Medical Discovery Institute, Orlando, Florida, USA.

出版信息

JCI Insight. 2018 Jun 21;3(12). doi: 10.1172/jci.insight.99762.

DOI:10.1172/jci.insight.99762
PMID:29925686
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6124396/
Abstract

While several molecular targets are under consideration, mechanistic underpinnings of the transition from uncomplicated nonalcoholic fatty liver disease (NAFLD) to nonalcoholic steatohepatitis (NASH) remain unresolved. Here we apply multiscale chemical profiling technologies to mouse models of deranged hepatic ketogenesis to uncover potential NAFLD driver signatures. Use of stable-isotope tracers, quantitatively tracked by nuclear magnetic resonance (NMR) spectroscopy, supported previous observations that livers of wild-type mice maintained long term on a high-fat diet (HFD) exhibit a marked increase in hepatic energy charge. Fed-state ketogenesis rates increased nearly 3-fold in livers of HFD-fed mice, a greater proportionate increase than that observed for tricarboxylic acid (TCA) cycle flux, but both of these contributors to overall hepatic energy homeostasis fueled markedly increased hepatic glucose production (HGP). Thus, to selectively determine the role of the ketogenic conduit on HGP and oxidative hepatic fluxes, we studied a ketogenesis-insufficient mouse model generated by knockdown of the mitochondrial isoform of 3-hydroxymethylglutaryl-CoA synthase (HMGCS2). In response to ketogenic insufficiency, TCA cycle flux in the fed state doubled and HGP increased more than 60%, sourced by a 3-fold increase in glycogenolysis. Finally, high-resolution untargeted metabolomics and shotgun lipidomics performed using ketogenesis-insufficient livers in the fed state revealed accumulation of bis(monoacylglycero)phosphates, which also accumulated in livers of other models commonly used to study NAFLD. In summary, natural and interventional variations in ketogenesis in the fed state strongly influence hepatic energy homeostasis, glucose metabolism, and the lipidome. Importantly, HGP remains tightly linked to overall hepatic energy charge, which includes both terminal fat oxidation through the TCA cycle and partial oxidation via ketogenesis.

摘要

虽然有几个分子靶点正在研究中,但从简单的非酒精性脂肪性肝病(NAFLD)向非酒精性脂肪性肝炎(NASH)的转变的机制基础仍未解决。在这里,我们应用多尺度化学分析技术研究肝脏酮生成异常的小鼠模型,以揭示潜在的 NAFLD 驱动特征。使用稳定同位素示踪剂,通过核磁共振(NMR)光谱进行定量跟踪,支持了先前的观察结果,即长期高脂肪饮食(HFD)喂养的野生型小鼠肝脏表现出明显的肝能量电荷增加。HFD 喂养的小鼠肝脏中的进食状态酮生成率增加了近 3 倍,这比三羧酸(TCA)循环通量的比例增加更大,但这两者都是整体肝能量平衡的贡献者,导致肝葡萄糖生成(HGP)显著增加。因此,为了选择性地确定酮生成途径对 HGP 和氧化肝通量的作用,我们研究了一种由线粒体同工型 3-羟甲基戊二酰辅酶 A 合酶(HMGCS2)敲低产生的酮生成不足的小鼠模型。在酮生成不足的情况下,进食状态下的 TCA 循环通量增加了一倍,HGP 增加了 60%以上,来源是糖原分解增加了 3 倍。最后,使用酮生成不足的肝脏在进食状态下进行的高分辨率非靶向代谢组学和鸟枪法脂质组学研究表明,双(单酰基甘油)磷酸酯的积累,这也在其他常用的 NAFLD 研究模型的肝脏中积累。总之,进食状态下酮生成的自然和干预变化强烈影响肝能量平衡、葡萄糖代谢和脂质组。重要的是,HGP 仍然与整体肝能量电荷紧密相关,其中包括通过 TCA 循环的末端脂肪氧化和通过酮生成的部分氧化。

相似文献

1
Hepatic ketogenic insufficiency reprograms hepatic glycogen metabolism and the lipidome.肝酮生成不足会重新编程肝糖原代谢和脂质组。
JCI Insight. 2018 Jun 21;3(12). doi: 10.1172/jci.insight.99762.
2
Ketogenesis prevents diet-induced fatty liver injury and hyperglycemia.生酮作用可预防饮食诱导的脂肪肝损伤和高血糖。
J Clin Invest. 2014 Dec;124(12):5175-90. doi: 10.1172/JCI76388. Epub 2014 Oct 27.
3
Branched chain amino acids and carbohydrate restriction exacerbate ketogenesis and hepatic mitochondrial oxidative dysfunction during NAFLD.支链氨基酸和碳水化合物限制在非酒精性脂肪性肝病期间加剧酮生成和肝线粒体氧化功能障碍。
FASEB J. 2020 Nov;34(11):14832-14849. doi: 10.1096/fj.202001495R. Epub 2020 Sep 12.
4
Lipotoxicity in steatohepatitis occurs despite an increase in tricarboxylic acid cycle activity.尽管三羧酸循环活性增加,但脂肪性肝炎中仍会发生脂毒性。
Am J Physiol Endocrinol Metab. 2016 Apr 1;310(7):E484-94. doi: 10.1152/ajpendo.00492.2015. Epub 2016 Jan 26.
5
Impaired ketogenesis and increased acetyl-CoA oxidation promote hyperglycemia in human fatty liver.在人类脂肪肝中,酮生成受损和乙酰辅酶 A 氧化增加会促进高血糖。
JCI Insight. 2019 Apr 23;5(11):127737. doi: 10.1172/jci.insight.127737.
6
Hmgcs2-mediated ketogenesis modulates high-fat diet-induced hepatosteatosis.Hmgcs2 介导的酮体生成调节高脂肪饮食诱导的肝脂肪变性。
Mol Metab. 2022 Jul;61:101494. doi: 10.1016/j.molmet.2022.101494. Epub 2022 Apr 12.
7
Cross-talk between branched-chain amino acids and hepatic mitochondria is compromised in nonalcoholic fatty liver disease.在非酒精性脂肪性肝病中,支链氨基酸与肝脏线粒体之间的相互作用受到损害。
Am J Physiol Endocrinol Metab. 2015 Aug 15;309(4):E311-9. doi: 10.1152/ajpendo.00161.2015. Epub 2015 Jun 9.
8
Impact of exenatide on mitochondrial lipid metabolism in mice with nonalcoholic steatohepatitis.EXENATIDE 对非酒精性脂肪性肝炎小鼠线粒体脂质代谢的影响。
J Endocrinol. 2019 Jun 1;241(3):293-305. doi: 10.1530/JOE-19-0007.
9
Aerobic capacity and hepatic mitochondrial lipid oxidation alters susceptibility for chronic high-fat diet-induced hepatic steatosis.有氧能力和肝脏线粒体脂质氧化会改变慢性高脂饮食诱导的肝脂肪变性的易感性。
Am J Physiol Endocrinol Metab. 2016 Oct 1;311(4):E749-E760. doi: 10.1152/ajpendo.00178.2016. Epub 2016 Sep 6.
10
Arachidyl amido cholanoic acid improves liver glucose and lipid homeostasis in nonalcoholic steatohepatitis AMPK and mTOR regulation.花生四烯酰氨基胆酸改善非酒精性脂肪性肝炎中的肝脏葡萄糖和脂质稳态:AMPK和mTOR调节。
World J Gastroenterol. 2020 Sep 14;26(34):5101-5117. doi: 10.3748/wjg.v26.i34.5101.

引用本文的文献

1
Ketone metabolites in metabolic dysfunction-associated steatotic liver disease progression: optimizing keto-therapeutic strategies.代谢功能障碍相关脂肪性肝病进展中的酮类代谢产物:优化酮治疗策略
Am J Physiol Endocrinol Metab. 2025 Aug 1;329(2):E290-E301. doi: 10.1152/ajpendo.00178.2025. Epub 2025 Jul 7.
2
Ketogenesis mitigates metabolic dysfunction-associated steatotic liver disease through mechanisms that extend beyond fat oxidation.生酮作用通过超越脂肪氧化的机制减轻与代谢功能障碍相关的脂肪性肝病。
J Clin Invest. 2025 Apr 24;135(12). doi: 10.1172/JCI191021. eCollection 2025 Jun 16.
3
The neglected PCK1/glucagon (inter)action in nutrient homeostasis beyond gluconeogenesis: Disease pathogenesis and treatment.糖异生之外,营养稳态中被忽视的磷酸烯醇式丙酮酸羧激酶1/胰高血糖素(相互)作用:疾病发病机制与治疗
Mol Metab. 2025 Apr;94:102112. doi: 10.1016/j.molmet.2025.102112. Epub 2025 Feb 13.
4
Ketogenesis supports hepatic polyunsaturated fatty acid homeostasis via fatty acid elongation.生酮作用通过脂肪酸延长来维持肝脏多不饱和脂肪酸的稳态。
Sci Adv. 2025 Jan 31;11(5):eads0535. doi: 10.1126/sciadv.ads0535. Epub 2025 Jan 29.
5
Targeting ketone body metabolism to treat fatty liver disease.靶向酮体代谢治疗脂肪肝。
J Pharm Pharm Sci. 2024 Sep 30;27:13375. doi: 10.3389/jpps.2024.13375. eCollection 2024.
6
Restoration of HMGCS2-mediated ketogenesis alleviates tacrolimus-induced hepatic lipid metabolism disorder.恢复 HMGCS2 介导的酮体生成可减轻他克莫司诱导的肝脂质代谢紊乱。
Acta Pharmacol Sin. 2024 Sep;45(9):1898-1911. doi: 10.1038/s41401-024-01300-0. Epub 2024 May 17.
7
Relationship between serum β-hydroxybutyrate and hepatic fatty acid oxidation in individuals with obesity and NAFLD.肥胖症和非酒精性脂肪性肝病患者血清β-羟丁酸与肝内脂肪酸氧化的关系。
Am J Physiol Endocrinol Metab. 2024 Apr 1;326(4):E493-E502. doi: 10.1152/ajpendo.00336.2023. Epub 2024 Feb 21.
8
Myosteatosis: Diagnosis, pathophysiology and consequences in metabolic dysfunction-associated steatotic liver disease.肌脂肪变性:代谢功能障碍相关脂肪性肝病的诊断、病理生理学及后果
JHEP Rep. 2023 Nov 14;6(2):100963. doi: 10.1016/j.jhepr.2023.100963. eCollection 2024 Feb.
9
Intact ketogenesis predicted reduced risk of moderate-severe metabolic-associated fatty liver disease assessed by liver transient elastography in newly diagnosed type 2 diabetes.新诊断 2 型糖尿病患者中,通过肝脏瞬时弹性成像评估,未受损酮体生成可降低中重度代谢相关脂肪性肝病风险。
Front Endocrinol (Lausanne). 2024 Jan 8;14:1306134. doi: 10.3389/fendo.2023.1306134. eCollection 2023.
10
Quantitative proteomics analysis based on data-independent acquisition reveals the effect of Shenling Baizhu powder (SLP) on protein expression in MAFLD rat liver tissue.基于数据非依赖采集的定量蛋白质组学分析揭示了参苓白术散(SLP)对非酒精性脂肪性肝炎(MAFLD)大鼠肝组织蛋白质表达的影响。
Clin Proteomics. 2023 Dec 1;20(1):55. doi: 10.1186/s12014-023-09442-9.

本文引用的文献

1
Endogenous Glucose Production and Hormonal Changes in Response to Canagliflozin and Liraglutide Combination Therapy.卡格列净和利拉鲁肽联合治疗对内源性葡萄糖生成和激素变化的影响。
Diabetes. 2018 Jun;67(6):1182-1189. doi: 10.2337/db17-1278. Epub 2018 Mar 30.
2
Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis.非酒精性脂肪性肝炎的病因、发病机制及治疗
N Engl J Med. 2017 Nov 23;377(21):2063-2072. doi: 10.1056/NEJMra1503519.
3
Loss of hepatic AMP-activated protein kinase impedes the rate of glycogenolysis but not gluconeogenic fluxes in exercising mice.肝脏中AMP激活的蛋白激酶缺失会阻碍运动小鼠的糖原分解速率,但不会影响糖异生通量。
J Biol Chem. 2017 Dec 8;292(49):20125-20140. doi: 10.1074/jbc.M117.811547. Epub 2017 Oct 16.
4
Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases.非酒精性脂肪性肝病作为代谢和肝脏疾病的纽带。
Cell Metab. 2018 Jan 9;27(1):22-41. doi: 10.1016/j.cmet.2017.08.002. Epub 2017 Aug 31.
5
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.卡格列净与 2 型糖尿病的心血管和肾脏事件。
N Engl J Med. 2017 Aug 17;377(7):644-657. doi: 10.1056/NEJMoa1611925. Epub 2017 Jun 12.
6
Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics.酮体在燃料代谢、信号传导和治疗中的多维作用
Cell Metab. 2017 Feb 7;25(2):262-284. doi: 10.1016/j.cmet.2016.12.022.
7
A Non-invasive Method to Assess Hepatic Acetyl-CoA In Vivo.一种评估体内肝脏乙酰辅酶A的非侵入性方法。
Cell Metab. 2017 Mar 7;25(3):749-756. doi: 10.1016/j.cmet.2016.12.017. Epub 2017 Jan 19.
8
Lactate metabolism is associated with mammalian mitochondria.乳酸代谢与哺乳动物线粒体相关。
Nat Chem Biol. 2016 Nov;12(11):937-943. doi: 10.1038/nchembio.2172. Epub 2016 Sep 12.
9
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.营养性酮症改变燃料偏好,从而提高运动员的耐力表现。
Cell Metab. 2016 Aug 9;24(2):256-68. doi: 10.1016/j.cmet.2016.07.010. Epub 2016 Jul 27.
10
Exogenous Fatty Acids Are the Preferred Source of Membrane Lipids in Proliferating Fibroblasts.外源性脂肪酸是增殖成纤维细胞中膜脂质的首选来源。
Cell Chem Biol. 2016 Apr 21;23(4):483-93. doi: 10.1016/j.chembiol.2016.03.007. Epub 2016 Mar 31.